|Basis of Allotment|
(THIS IS ONLY AN ADVERTISEMENT FOR INFORMATION PURPOSES AND NOT A PROSPECTUS ANNOUNCEMENT. NOT FOR DISTRIBUTION OUTSIDE INDIA.)
BAJAJ HEALTHCARE LIMITED
Our Company was Incorporated as Bajaj Healthcare Pvt. Ltd. on July 15,1993 under the Companies Act, 1956, with the Registrar of Companies, Mumbai bearing Registration Number - 072892. The status of our Company was changed to a public limited company and the name of our Company was changed to Bajaj Healthcare Ltd. by a special resolution passed on March 15,2005. A fresh certificate of Incorporation consequent to the change of name was granted to our Company on March 31,2005, by the Registrar of Companies, Mumbai. For further details, please see chapter titled "History and Certain Corporate Affairs" beginning on page no. 140 of the Prospectus.
Registered Office: N- 216, MIDC, Tarapur, Boisar, Dist. Thane -
401 506; Tel No.: +91-2525 - 655208/655209; Fax No.: +91 - 2525 - 661074
BASIS OF ALLOTMENT
PUBLIC OFFER OF 18,17,600 EQUITY SHARES OF RS 10 EACH ("EQUITY SHARES") OF BAJAJ HEALTHCARE LIMITED ("BHL" OR THE "COMPANY") FOR CASH AT A PRICE OF RS 170/- PER SHARE (THE "OFFER PRICE"), AGGREGATING TO RS 3,089.92 LAKHS ("THE OFFER") CONSISTING OF FRESH ISSUE OF 1,49,600 EQUITY SHARES AGGREGATING TO RS 254.32 LAKHS AND AN OFFER FOR SALE OF 16,68,000 EQUITY SHARES BY THE SELLING SHAREHOLDERS AGGREGATING TO RS 2,835.60 LAKHS ("OFFER FOR SALE"), OF WHICH 91,200 EQUITY SHARES OF RS 10 EACH WILL BE RESERVED FOR SUBSCRIPTION BY MARKET MAKERS TO THE OFFER (THE "MARKET MAKER RESERVATION PORTION"). THE OFFER LESS MARKET MAKER RESERVATION PORTION I.E. OFFER OF 17,26,400 EQUITY SHARES OF RS 10 EACH IS HEREINAFTER REFERRED TO AS THE "NET OFFER". THE OFFER AND THE NET OFFER WILL CONSTITUTE 26.34% AND 25.02%, RESPECTIVELY OF THE POST OFFER PAID UP EQUITY SHARE CAPITAL OF THE COMPANY.
THE FACE VALUE OF THE EQUITY SHARES IS RS
10 EACH AND
The Equity Shares of the Company are proposed to be listed on the SME Platform of BSE
Limited ("BSE"). In terms of the Chapter XB of the SEBI (ICDR) Regulations,
2009, as amended from time to time, we are not required to obtain an In-princlple listing
approval from BSE. However, our Company has received an approval via letter dated March
08, 2016 from BSE for using Its name In the Offer Document for listing of our shares on
the SME Platform of BSE. BSE shall be the Designated Stock Exchange for the purpose of
this Offer. The trading is proposed to be commenced on May 10,2016*.
The Offer Is being made through the Fixed Price process, the allocation In the Net Offer to the Public category shall be made as per Regulation 43(4) of the SEBI (ICDR) Regulations, 2009, as amended from time to time, wherein a minimum of 50% of the Net Offer of shares to the Public shall Initially be made available for allotment to Retail Individual Investors. The balance of Net Offer of Shares to the public shall be made available for allotment to Individual Applicants other than Retail Individual Investors and other Investors, Including Corporate Bodies / Institutions Irrespective of number of shares applied for. Under subscription, If any, in any of the categories, would be allowed to be met with spill-over from any of the other categories or a combination of categories at the discretion of our Company in consultation with the Lead Manager and the Designation Stock Exchange. Such inter-se spill over, If any, would be affected in accordance with applicable laws, rules, regulations and guidelines. All Investors shall participate in the Offer only through APPLICATIONS SUPPORTED BY BLOCKED AMOUNT ("ASBA") process by providing the details of their respective bank accounts In which the corresponding application amounts were blocked by Self Certified Syndicate Banks (the "SCSBs").
The Net Offer has received 561 applications for 19,92,000 Equity Shares resulting in 1.15 times subscription. The details of the applications received In the Net Offer (before and after technical rejections & withdrawal) are as follows: Detail of the Applications Received
Note: The Offer also includes 91,200 Equity Shares reserved for Market Maker, which was subscribed by 1.00 times and there were no Technical Rejection & any withdrawal.
In the event of oversubscription, the allotment will be made on a proportionate basis in marketable lots. There was under-subscriptlon of 4,90,400 Equity Shares In Retail Category & over subscription 7,37,600 Equity Shares In Non - Retail Category, before spill over. The unsubscribed portion of Retail Category i.e. 4,90,400 Equity Share has been added to the Non-Retail Category. The Basis of Allotment was finalised In consultation with the Designated Stock Exchange - BSE Ltd on May 05,2016.
A) Allocation to Marker Maker (After Technical Rejections & Withdrawals): The Basis of Allotment to the Market Maker, at the Offer Price of Rs 170 per Equity Share, was finalised in consultation with BSE. The category was subscribed by 1.00 times. The total number of shares allotted in this category is 91,200 Equity Shares.
The category wise details of the Basis of Allotment are as under:
B) Allocation to Retail Individual Investors (After Technical Rejections & Withdrawals): The Basis of Allotment to the Retail Individual Investors, at the Offer Price of ? 170 per Equity Share, was finalised In consultation with BSE. The total number of shares allocated In this category is 8,63,200 Equity Shares. The category was subscribed by 0.43 times.
The Category-wise details of the Basis of Allotment are as under:
C) Allocation to Non - Retails Category (After Technical Rejections & Withdrawals): The Basis of Allotment to the Non - Retail Investors, at the Offer Price of Rs 170/- per Equity Share, was finalised In consultation with BSE. The total number of shares allocated In this category Is 13,53,600 Equity Shares Including unsubscribed portion of Retail Category. The category was subscribed by 1.18 times.
The Category-wise details of the Basis of Allotment are as under:
The Board of Directors of the Company at its meeting held on May 06,2016 has taken on record the Basis of Allotment of Equity Shares, as approved by the Designated Stock Exchange viz. BSE and has authorized the corporate action for the allotment of the Equity Shares to various successful applicants. The CAN and allotment advice and/ or notices have been dispatched to the address of the investors as registered with the depositories. Further, the instructions to Self Certified Syndicate Banks have been processed on May 07,2016 for unblocking of funds. The Equity Shares allotted to successful applicants are been credited to their beneficiary accounts subject to validation of the account details with the depositories concerned. In case the same is not received within prescribed time, investors may contact the Registrar to the Offer at the address given below. The Company is taking steps to get the Equity Shares admitted for trading on the SME Platform of BSE Limited within 6 working days from the Closure of the Offer. The trading is proposed to be commenced on May 10, 2016 subject to receipt of listing and trading approvals from BSE.
Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus dated April 12,2016 ("Prospectus"). INVESTORS PLEASE NOTE
The details of the allotment made has been hosted on the website of the Registrar to
the Offer, Sharex Dynamic (I) Private Limited at Website: www.sharexindia.com
SHAREX DYNAMIC (I) PRIVATE LIMITED
LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARE ON LISTING OR THE BUSINESS PROSPECTS OF BAJAJ HEALTHCARE LIMITED.
BAJAJ HEALTHCARE LIMITED is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make a Public Offer of its Equity Shares and has filed the Prospectus with Registrar of Companies, Mumbai. The Prospectus shall be available on the websites of the Company, the BSE and the LM at www.bajajhealth.com, www.bseindia.com and www.afsl.co.in respectively. Applicants should note that investment in equity shares involves a high degree of risk and for details relating to the same, see the Prospectus, including, the section titled "Risk Factors" beginning on page 10 of the Prospectus.
The Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "U.S. Securities Act"), and may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. Accordingly, the Equity Shares are being offered and sold (i) within the United States to persons reasonably believed to be qualified institutional investors (as defined in Rule 144A under the U.S. Securities Act) pursuant to Rule 144A under the U.S. Securities Act and (ii) outside the United States in offshore transactions in reliance on Regulation S under the U.S. Securities Act and applicable laws of the jurisdictions where such offers and sales occur. Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.